Organization · Venture Capital
Panacea Venture
Panacea Venture, also known as Panacea Capital, is a healthcare-focused venture capital firm founded in 2017. It invests in early-stage life science companies globally, with a strong emphasis on therapeutics and innovative healthcare solutions.
Overview
What Panacea Venture does
What Panacea Venture is
Panacea Venture, also known as Panacea Capital, is a healthcare-focused venture capital firm founded in 2017. It invests in early-stage life science companies globally, with a strong emphasis on therapeutics and innovative healthcare solutions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- May 4, 2026
Official channels
Find Panacea Venture elsewhere
Open the official website or a supported primary organization account.
Capability profile
Panacea Venture as a funder
Investment thesis
Panacea Venture focuses on transforming lives through promising innovation in life sciences, leveraging a borderless execution model to connect portfolio companies with global markets and major pharmaceutical channels.
Focus narrative
Panacea Capital primarily invests in therapeutics, utilizing a strategy that includes incubation and early-stage funding, global asset acceleration in collaboration with multinational pharmaceutical companies, and public market investments. The firm aims to identify and support innovations that address unmet medical needs, focusing on programs with strong foundational science and meaningful clinical impact.
Value beyond capital
Panacea Capital adds value to its portfolio companies through a 'business development first' mindset, actively facilitating licensing deals, M&A exits, and strategic partnerships as primary levers for value creation. The firm connects portfolio companies with platform technology partners globally, enhancing their growth potential and market reach.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo
- Sectors
- Biotech · Healthcare · Digital Health · Diagnostics
- Regions
- Global · North America · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
- Recorded notable exits
- Connect Biopharma Holdings and Kindstar Globalgene Technology
Portfolio context
Notable portfolio companies include: Actym Therapeutics: Developing next-generation immunotherapeutic modalities. Eos BioInnovation, LLC: Focused on innovative regenerative medicine. Myrtelle: Developing treatments for neurodegenerative diseases. Harvest Integrated Research Organization (HiRO): A clinical contract research organization providing a full range of solutions and services. Human Longevity: Aiming to increase longevity through early detection and intervention. Kindstar Global: A large high-end esoteric testing service provider in China. Juventas Therapeutics: Focused on cell therapy. Kainova Therapeutics: Developing immuno-oncology therapies. BioFront Therapeutics: Discovering and developing therapeutics for cardiometabolic diseases. GT Apeiron Therapeutics: Targeting the cancer cell cycle with next-generation CDK inhibitors.
Common questions
What to know about Panacea Venture
Upseed classifies Panacea Venture under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.